CBMG Selected for Inclusion in the Russell 3000 Index
June 16, 2015 09:17 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and PALO ALTO, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
Cellular Biomedicine Group Enters Into Definitive Agreement to Acquire CD40LGVAX Vaccine and Related Technologies and Know-How Which Will be Used in a Pending PD-1 Combination Clinical Trial in the U.S. for Non-Small Cell Lung Cancer (NSCLC)
June 09, 2015 08:30 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and PALO ALTO, Calif., June 9, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new...
Cellular Biomedicine Group Announces Publication of Human Adipose-Derived Progenitor Cells to Treat Knee Osteoarthritis
June 05, 2015 08:30 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and PALO ALTO, Calif., June 5, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
Cellular Biomedicine Group to Provide Business and Clinical Updates at Jefferies 2015 Global Healthcare Conference
May 29, 2015 09:00 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and PALO ALTO, Calif., May 29, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
Cellular Biomedicine Group Expands and Strengthens Leadership Team
May 27, 2015 08:00 ET
|
Cellular Biomedicine Group Inc.
PALO ALTO, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...
Cellular Biomedicine Group Announces Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program
May 22, 2015 09:17 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and PALO ALTO, Calif., May 22, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
Cellular Biomedicine Group Reports First Quarter 2015 Financial Results and Provides Business Highlights
May 18, 2015 06:10 ET
|
Cellular Biomedicine Group Inc.
PALO ALTO, Calif., May 18, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group, Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...
Cellular Biomedicine Group, Inc. Featured on Wide World of Stocks Television
May 12, 2015 09:30 ET
|
Cellular Biomedicine Group Inc.
PALO ALTO, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...
Cellular Biomedicine Group Responds to Purported Class Action Lawsuit
April 30, 2015 18:30 ET
|
Cellular Biomedicine Group Inc.
PALO ALTO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...
Cellular Biomedicine Group Appoints Two New Members to Scientific Advisory Board
April 30, 2015 09:30 ET
|
Cellular Biomedicine Group Inc.
PALO ALTO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...